cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results
cbdMD, Inc. (NYSE American: YCBD), a leading CBD company, has announced it will host a conference call to discuss its second quarter fiscal year 2025 financial results for the period ending March 31, 2025. The conference call is scheduled for Thursday, May 15, 2025, at 4:20 p.m. Eastern Time. Participants can join via USA/Canada (833-821-3524) or International (647-846-2919) dial-in numbers. A replay will be available through dedicated phone lines and a webcast replay link will remain accessible until May 15, 2026.
cbdMD, Inc. (NYSE American: YCBD), una delle principali aziende nel settore del CBD, ha annunciato che terrà una conference call per discutere i risultati finanziari del secondo trimestre dell'anno fiscale 2025 relativo al periodo terminato il 31 marzo 2025. La conference call è programmata per giovedì 15 maggio 2025 alle 16:20 ora della costa orientale. I partecipanti potranno collegarsi tramite i numeri telefonici USA/Canada (833-821-3524) o Internazionali (647-846-2919). Una registrazione sarà disponibile tramite linee telefoniche dedicate e un link per riascoltare la webcast resterà accessibile fino al 15 maggio 2026.
cbdMD, Inc. (NYSE American: YCBD), una empresa líder en CBD, ha anunciado que realizará una conferencia telefónica para discutir sus resultados financieros del segundo trimestre del año fiscal 2025 correspondiente al período que finaliza el 31 de marzo de 2025. La conferencia telefónica está programada para el jueves 15 de mayo de 2025 a las 4:20 p.m., hora del Este. Los participantes podrán unirse a través de los números de marcación para EE. UU./Canadá (833-821-3524) o Internacional (647-846-2919). Una repetición estará disponible mediante líneas telefónicas dedicadas y un enlace para reproducir la webcast permanecerá accesible hasta el 15 de mayo de 2026.
cbdMD, Inc. (NYSE American: YCBD)는 선도적인 CBD 기업으로서 2025 회계연도 2분기 재무 결과를 논의하기 위한 컨퍼런스 콜을 개최할 예정임을 발표했습니다. 해당 기간은 2025년 3월 31일에 종료됩니다. 컨퍼런스 콜은 2025년 5월 15일 목요일 동부 표준시 오후 4시 20분에 예정되어 있습니다. 참가자는 미국/캐나다(833-821-3524) 또는 국제 전화(647-846-2919) 번호를 통해 참여할 수 있습니다. 다시 듣기 서비스는 전용 전화선을 통해 제공되며, 웹캐스트 재생 링크는 2026년 5월 15일까지 이용 가능합니다.
cbdMD, Inc. (NYSE American : YCBD), une entreprise leader dans le domaine du CBD, a annoncé qu'elle tiendra une conférence téléphonique pour discuter des résultats financiers du deuxième trimestre de l'exercice 2025 pour la période se terminant le 31 mars 2025. La conférence téléphonique est prévue pour le jeudi 15 mai 2025 à 16h20, heure de l'Est. Les participants peuvent se joindre via les numéros d'appel USA/Canada (833-821-3524) ou internationaux (647-846-2919). Une rediffusion sera disponible via des lignes téléphoniques dédiées et un lien de rediffusion du webcast restera accessible jusqu'au 15 mai 2026.
cbdMD, Inc. (NYSE American: YCBD), ein führendes CBD-Unternehmen, hat angekündigt, eine Telefonkonferenz abzuhalten, um die Finanzergebnisse des zweiten Quartals des Geschäftsjahres 2025 für den Zeitraum bis zum 31. März 2025 zu besprechen. Die Telefonkonferenz ist für Donnerstag, den 15. Mai 2025, um 16:20 Uhr Eastern Time geplant. Teilnehmer können über die Einwahlnummern USA/Kanada (833-821-3524) oder international (647-846-2919) teilnehmen. Eine Aufzeichnung wird über spezielle Telefonleitungen verfügbar sein, und ein Webcast-Wiedergabelink bleibt bis zum 15. Mai 2026 zugänglich.
- None.
- None.
Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.
CONFERENCE CALL DETAILS
| Thursday, May 15, 2025, 4:20 p.m. Eastern Time | ||
| USA/Canada: | 833-821-3524 | |
| International: | 647-846-2919 | |
| Teleconference Replay dial in: | ||
| USA/Canada: | 855-669-9658 | |
| International: | 412-317-0088 | |
| Replay Passcode: | 7254091 | |
| Webcast/Webcast Replay link - available through May 15, 2026: | ||
https://www.gowebcasting.com/14065
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced THC-free1 CBD products and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products and our ATRx brand features functional mushroom products. In addition, we operate Herbal Oasis, a premium, award winning THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, ATRxlabs.com, or Herbaloasis.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251499
FAQ
When is cbdMD (YCBD) reporting Q2 2025 earnings?
How can I join the cbdMD (YCBD) Q2 2025 earnings call?
How long will the cbdMD (YCBD) Q2 2025 earnings call replay be available?
What period will cbdMD's (YCBD) Q2 2025 earnings report cover?
